CME — CME Share Price
Last trade - 00:00- $71.31bn
- $72.85bn
- $4.69bn
- 58
- 33
- 87
- 64
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 23.99 | ||
| PEG Ratio (f) | 2.12 | ||
| EPS Growth (f) | 12.74% | ||
| Dividend Yield (f) | 3.91% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.55 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 27.26 | ||
| Price to Sales | 14.73 | ||
| EV to EBITDA | 20.08 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.64% | ||
| Return on Equity | 10.55% | ||
| Operating Margin | 67.24% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 3,644.7 | 4,309.4 | 4,868 | 4,883.6 | 4,689.7 | 5,043.58 | 5,261.53 | 5.46% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +157.29 | -50.98 | +3.51 | -0.61 | +8.19 | +25.35 | +6.33 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CME Group Inc. provides products across all asset classes, by trading futures, options, cash and over-the-counter (OTC) products. The Company offers a range of products across interest rates, equity indexes, foreign exchange (FX), agricultural commodities, energy and metals. It also offers cash and repo fixed income trading through BrokerTec, and cash and OTC FX trading through electronic broking services (EBS). The Company’s segment consists of the Chicago Mercantile Exchange Inc. (CME), Board of Trade of the City of Chicago, Inc. (CBOT), New York Mercantile Exchange, Inc. (NYMEX), Commodity Exchange, Inc. (COMEX) and its cash markets business. In addition, it operates central counterparty clearinghouses. The Company offers clearing, settlement and guarantees for all products cleared through the clearinghouse. Its subsidiaries include Astley & Pearce Limited, Board of Trade of the City of Chicago, Inc., BrokerTec Americas LLC, BrokerTec Europe Limited and BrokerTec Holdings Inc.
Directors
- Terrence Duffy CHM (62)
- Charles Carey VCH (67)
- John Pietrowicz CFO (57)
- Sunil Cutinho CEX (49)
- Hilda Piell CHO (53)
- Jack Tobin CAO (57)
- Kevin Kometer CIO (56)
- Kathleen Cronin GCN (57)
- Julie Holzrichter SMD (52)
- Derek Sammann SMD (52)
- Sean Tully SMD (57)
- Kendal Vroman SMD (49)
- Julie Winkler SMD (46)
- Daniel Glickman LED (76)
- Michael Dennis DRC (40)
- Bryan Durkin DRC (59)
- Timothy Bitsberger IND (61)
- Dennis Chookaszian IND (77)
- Elizabeth Cook IND (60)
- Ana Dutra IND (56)
- Martin Gepsman IND (68)
- Larry Gerdes IND (72)
- William Hobert IND (57)
- Daniel Kaye IND (66)
- Phyllis Lockett IND (55)
- Deborah Lucas IND (62)
- Patrick Maloney IND (59)
- Patrick Mulchrone IND (63)
- Terry Savage IND (76)
- Rahael Seifu IND (39)
- William Shepard IND (74)
- Howard Siegel IND (64)
- Dennis Suskind IND (78)
- Robert Tierney IND (45)
- Last Annual
- December 31st, 2021
- Last Interim
- June 30th, 2022
- Incorporated
- August 2nd, 2001
- Public Since
- December 6th, 2002
- No. of Shareholders
- 6,105
- No. of Employees
- 3,480
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 359,436,435
- Address
- 20 S Wacker Dr, CHICAGO, 60606
- Web
- https://www.cmegroup.com/
- Phone
- +1 3129303011
- Auditors
- Ernst & Young LLP
Latest News for CME
Upcoming Events for CME
Dividend For CHME34.SA - 1.3102 BRL
Dividend For CME.OQ - 1.0000 USD
Q3 2022 CME Group Inc Earnings Release
Q4 2022 CME Group Inc Earnings Release
Similar to CME
ACI Worldwide
NASDAQ Global Select Market
Affirm Holdings
NASDAQ Global Select Market
Apollo Investment
NASDAQ Global Select Market
Applied Blockchain
NASDAQ Global Select Market
Argo Blockchain
NASDAQ Global Select Market
FAQ
As of Today at 19:04 UTC, shares in CME are trading at $198.40. This share price information is delayed by 15 minutes.
Shares in CME last closed at $198.40 and the price had moved by -3.67% over the past 365 days. In terms of relative price strength the CME share price has outperformed the S&P500 Index by +1.76% over the past year.
The overall consensus recommendation for CME is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The CME dividend yield is 1.92% based on the trailing twelve month period.
Last year, CME paid a total dividend of $3.80, and it currently has a trailing dividend yield of 1.92%.Looking ahead, shares in CME are due to go ex-dividend on 2022-09-08 and the next dividend pay date is 2022-09-27.
CME are due to go ex-dividend on 2022-09-08 and the next dividend pay date is 2022-09-27. The historic dividend yield on CME shares is currently 1.92%.
To buy shares in CME you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $198.40, shares in CME had a market capitalisation of $71.31bn.
Here are the trading details for CME:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: CME
Based on an overall assessment of its quality, value and momentum CME is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in CME is $225.43. That is 13.62% above the last closing price of $198.40.
Analysts covering CME currently have a consensus Earnings Per Share (EPS) forecast of $7.96 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CME. Over the past six months, its share price has underperformed the S&P500 Index by -13.94%.
As of the last closing price of $198.40, shares in CME were trading -9.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The CME PE ratio based on its reported earnings over the past 12 months is 23.99. The shares last closed at $198.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
CME's management team is headed by:
- Terrence Duffy - CHM
- Charles Carey - VCH
- John Pietrowicz - CFO
- Sunil Cutinho - CEX
- Hilda Piell - CHO
- Jack Tobin - CAO
- Kevin Kometer - CIO
- Kathleen Cronin - GCN
- Julie Holzrichter - SMD
- Derek Sammann - SMD
- Sean Tully - SMD
- Kendal Vroman - SMD
- Julie Winkler - SMD
- Daniel Glickman - LED
- Michael Dennis - DRC
- Bryan Durkin - DRC
- Timothy Bitsberger - IND
- Dennis Chookaszian - IND
- Elizabeth Cook - IND
- Ana Dutra - IND
- Martin Gepsman - IND
- Larry Gerdes - IND
- William Hobert - IND
- Daniel Kaye - IND
- Phyllis Lockett - IND
- Deborah Lucas - IND
- Patrick Maloney - IND
- Patrick Mulchrone - IND
- Terry Savage - IND
- Rahael Seifu - IND
- William Shepard - IND
- Howard Siegel - IND
- Dennis Suskind - IND
- Robert Tierney - IND